We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Gene Therapy for Niemann-Pick Type a Diseases Moves Forward

News   Aug 22, 2019 | Original story from The Ohio State University College of Medicine

 
Gene Therapy for Niemann-Pick Type a Diseases Moves Forward

Credit: Pixabay

 
 
 

RELATED ARTICLES

$27 Million Grant Focuses on the Future of Biomanufacturing

News

A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.

READ MORE

Alzheimer's Risk Gene Impairs Brain's Immune Cells

News

A study carried out with a new human stem cell-derived model reveals that the most prevalent genetic risk factor of Alzheimer's disease (AD), apolipoprotein E4 (APOE4), impairs the function of human brain immune cells, microglia. These findings pave the way for new, effective treatment approaches for AD. The results were published in Stem Cell Reports.

READ MORE

Treating Blood Cancers With a Low-cost Arthritis Drug

News

A simple arthritis drug could be an effective, low-cost solution to treat patients with blood cancers, according to a new study by the University of Sheffield.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE